“Development of Nanocrystal Formulations With Improved Dissolution And Bioavailability for BCS Classs-II Drug- Quitapine”. Journal of Pharmaceutical Negative Results (August 1, 2022): 5113–5120. Accessed June 9, 2026. https://mail.pnrjournal.com/index.php/home/article/view/9612.